Nestlé revealed it will close two of its Health Science plants in the United States. The Swiss company explained that this move is a strategy to increase efficiency in its health nutrition business unit.
Nestlé Health Science is the company’s division that is focused on the research, development, and manufacturing of healthy and medical nutrition products. It is mainly known for its Nutren and Meritene brands. At any rate, it is said to be currently in the process of bringing together its supply chain network to boost efficiency.
The company issued a Worker Adjustment and Retraining Notification (WARN), and Nestlé Health Science’s director of project management and HR special projects, Chris Richardson, said in the memo that due to the closure of their two facilities, more than 300 employees are set to lose their jobs.
To be more exact, Richardson stated in the WARN that “312 positions will be eliminated on a permanent basis.” The two plants that would be shut down are those located in Findlay and Robinson Township, and the job cuts are expected to begin in late June.
“There are no bumping rights at the impacted facility. The employees have no elected collective bargaining representative,” the project management director added.
According to Penn Live News, Nestlé Health Sciences filed the WARN notice at the Pennsylvania Department of Industry. It was indicated in the memo that the company’s facilities at 600 Boyce Road, under the name of HVL LLC, and 112 Technology Drive in Pittsburgh, listed under the name Pure Encapsulations are set to cease operations.
The WARN Act is a government regulation that protects employees, communities, and even the families of workers in the U.S. This law provides protection by requiring companies and other employers to notify everyone if they are planning to close business. It is a must for this type of notice to be posted 60 days in advance.


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock 



